Financhill
Back

Edgewise Therapeutics Quote, Financials, Valuation and Earnings

Edgewise Therapeutics Price Quote

$17.98
+0.48 (+2.74%)
(Updated: June 28, 2024 at 11:05 AM ET)

Edgewise Therapeutics Key Stats

Sell
46
Edgewise Therapeutics (EWTX) is a Sell

Day range:
$17.06 - $17.55
52-week range:
$5.12 - $21.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.06%

Volume:
1.1M
Avg. volume:
621.3K
1-year change:
133.02%
Market cap:
$1.6B
Revenue:
$0
EPS:
$-1.55

How Much Does Edgewise Therapeutics Make?

Data Unavailable

Is Edgewise Therapeutics Growing As A Company?

Data Unavailable

Edgewise Therapeutics Stock Price Performance

What Is Edgewise Therapeutics 52-Week High & Low?

Edgewise Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Edgewise Therapeutics?

Is Edgewise Therapeutics Cash Flow Positive?

  • What Is EWTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$97.7M
  • What Is Edgewise Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $294.2M
  • What Is Edgewise Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$214.5M

Edgewise Therapeutics Return On Invested Capital

Data Unavailable

Edgewise Therapeutics Earnings Date & Stock Price

Edgewise Therapeutics Competitors

Edgewise Therapeutics Dividend Yield

Data Unavailable

Edgewise Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 19.12%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 32.50
Upside from Last Price: 85.71%

Major Shareholders

  • How many EWTX shares are owned by institutional investors?
    122.8M EWTX shares are owned by institutional investors
  • How many EWTX shares are owned by insiders?
    139.8K EWTX shares are owned by insiders